Results of a 24-Week Trial of Technosphere Insulin Versus Insulin Aspart in Type 2 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Results of a 24-Week Trial of Technosphere Insulin Versus Insulin Aspart in Type 2 Diabetes

Published:2021-01 Issue:1 Volume:27 Page:38-43
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Hoogwerf Byron J.,Pantalone Kevin M.,Basina Marina,Jones Marisa C.,Grant Marshall,Kendall David M.

Funder

MannKind Corporation

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Inhaled human insulin (Exubera(®)): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus;Schimke;Expert Rev Clin Pharmacol,2008

2. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: a 3-year randomized controlled trial;Skyler;Diabetes Res Clin Pract,2008

3. The design and performance of the Exubera pulmonary insulin delivery system;Harper;Diabetes Technol Ther,2007

4. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial;Rosenstock;Diabetes Technol Ther,2009

5. Exit Exubera. Inhalable insulin is withdrawn due to weak sales;Keegan;Diabetes Forecast,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis;Diabetes Technology & Therapeutics;2024-08-01

2. Insulin Management for Gestational and Type 2 Diabetes in Pregnancy;Obstetrics & Gynecology;2024-06-13

3. Prandial Insulins: A Person-Centered Choice;Current Diabetes Reports;2024-04-03

4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

5. Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies;Diabetes Therapy;2023-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3